Many Humans are in a losing relationship with Cosmos Nature,..let alone their Earthly Nature. 
~~Bottom line....Nature ALWAYS WINS folks!!
 
 When it comes to Nature, don't kid yourselves and/or ever go against Nature in any way, shape or form.
Which brings me to the dirty dealings of some that do…..the ones marketing and/or patenting synthetic forms/derivatives of the all~natural "Tree of Life"(Indian Hemp/Cannabis),…EW!!!( those of us who are awake know what I am talkin' about,..if you are wakin' up  right now,….GoOod Marnin' Sunshine!).
Ya see!!..Big Pharma certainly can't be helping anyone at all by polluting desperate & sick Humans with unnatural types of pharmaceutical tra$h like this.
 
 Nature's Indian Hemp/Cannabis has been around a whole lot longer than the FDA & their gang of big crooked friends,.. like the ones at Big Pharma, in association with, but not limited to these so-called "inventors"(see list of "inventors", and their so-called patents below)....hmmmph....PLEASE!!! ,…more like whores of Babylon…they aren't inventors, they are money bandits in lab coats, selling us out. They are committing genocide when marketing synthetics of any kind. ALL synthetics are poison & hazardous to the health of all living creatures/things,..synthetics are the worst of the worst. When it comes to my cannabinoids give 'em to me in NATURAL form ONLY Please!!.  Synthetics are a HUGE threat to nature, PLEASE, don't just "stand-by" until no Human is left to stand(by). Be Angel,..let your voices be heard(stray from the "herd"). 
 
                   Which brings me to this: Why when a loved one gets diagnosed with MS for example(or how about cancer,...yup that f*#@!&%! scourge cancer),… why shouldn't they be entitled to,…… whilst using their own free will, without anyones permission(doctors, ANY man-made laws/statutes or otherwise) to do what I have done, and research traditional medicines,..you know start from the early foundation, and beginnings of REAL MEDICINE,...ancient/traditional/natural medicines…..then follow the detours and many struggles of thee Cannabis Plant trying to save Humans,...and then many more detours hurdles and struggles for Humans who are ,..and/or have been awake, struggling to save other Humans,…AND a plant(Cannabis) that is restricted to grow freely as it did thousands of years ago.
 
 
We should be growing billions & billions & BILLIONS(gosh I LOVE Carl Sagan) of acres of cannabis on land all over thee World, for "BILLIONS " ;-)' of uses like for example: buildings, and building materials(tonnes of uses here alone folks), fuel(don't get me started), fibre, food & medicine. As for food and medicine, well I prefer the ol' y'know...natural medicine…..“Let food be thy medicine and medicine be thy food”~Hippocrates
 
 Yet,the "powers that be",(.. whilst using prohibition in combination with that bogus, & incorrect "schedule") are hellbent on stopping the Human population from consuming natural cannabinoids,..even if it is to improve our health and prolong our life…. you should easily see the problem, if you are awake.

 

 Meanwhile, this character Geoffery Guy (GW Pharmaceuticals)  can legally grow at least 10,000 cannabis plants at each of his secret cannabis farms/factories.
He's been granted permission,…. he is not considered a criminal??pffffttt ,..ask me,...I'll tell you he sure as hell is!!!! He is aiding and abetting crooks @ Big Pharma, including their investments, marketing wizardry, and those dirty synthetic so called "legal" script-pushers and their cohort$.
 
Below you can see about 28 "patents", "Applicants",…and so called "inventors" of pharmaceutical cannabinoids to be used for diseases, disorders, and health problems, such as cancers(yes brain cancer too),epilepsy,pain,cancer pain,arthritis,neuropathic pain,neurodegeneration (example:alzheimer's, "huntingdon's,parkinson's diseases", multiple sclerosis, Downs syndrome, prion disease, palsy, spinal cord injury,  or alcohol induced neurotoxicity ),nausea,vomiting,emesis,motion sickness or like conditions just to name a few. 
 
~ Strange how God never gets any credit for HIS invention huh?
 
 
 
 
 
So by all means save your loved ones , save yourself, but don't go against nature. 
 
 
 
Don't trust YOUR health into the pharmacy industry….they see you as their stock(…and I've seen/felt how they treat their "live" stocks).
 
 Educate, grow your own, invest in a medicinal cannabis THC, CBD, CBN, etc Cannabinoid test-kit, consume massive amounts of healthy cannabinoids, then naturally….feel the HEAL in real Healthcare.~Truth
 
 
Patents...
 
…for cancer and cancer related pain.

 

~~~

 
 
Inventor:
PAROLARO DANIELA [IT] 
MASSI PAOLA [IT] (+21)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP] (+1)
 
Abstract of  GB2478595  (A)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

One or more phytocannabinoids, selected from the group consisting of tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), tetrahydrocannabivarinic acid, (THCVA), tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), cannabidol (CBD), cannabigerol (CBG) and cannabichromene (CBC), are provided for use in the treatment of prostate cancer. Where present the THCVA is present in an isolated pytocannabinoid, the THCA, CBDA, CBD, CBG or CBC are present in the form of a BDS, and the THCV or CBDV are present in either an isolated form or in the form of a BDS. Alternatively, one or more phytocannabinoids or acid phytocannabinoids may be provided for use in the down regulation of ERK signaling and effect one or more of anti-proliferation, anti-metastasis or anti-angiogenesis in a human patient. Alternatively, one or more phytocannabinoid acid, excluding CBDA or CBDVA, may be provided, for use in medicine. Alternatively, a cannabis plant extract for use in medicine may comprise at least 50% w/w phytocannabinoid component, the non-phytocannabinoid component comprising a monoterpene fraction and a sesquiterpene fraction. Alternatively, an isolated CBD and/or CBD BDS may be provided for use in the treatment of a pre-cancerous symptom of colon cancer. Alternatively, a combination of phytocannabinoids together with a chemotherapeutic agent may be provided for use in the treatment of a glioma.

~~~

 
 
Inventor:
DIEZ GUILLERMO VELASCO [ES] 
PASTOR MANUEL GUZMAN [ES] (+3)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP]
 
Abstract of  GB2478072  (A)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

A combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD). for use in the treatment of a brain tumour, the compounds being in a ratio of the compounds are in the ratio of 5:1 to 1:5. The brain tumour may be a glioma/glioblastoma. The cannabinoids may be present as plant extracts and may be administered separately, sequentially or simultaneously.

~~~

 
 
Inventor:
WHITTLE BRIAN [GB] 
PAROLARO DANIELA [IT]
 
Applicant:
GW PHARMA LTD [GB]
 
Abstract of  US2012225136  (A1)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

The invention relates to the use of a cannabis plant extract or a cannabinoid as a pharmaceutically active agent in the inhibition of tumour cell migration.

~~~

 
 
Inventor:
DIEZ GUILLERMO VELASCO [ES] 
PASTOR MANUEL GUZMAN [ES] (+3)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP]
 
Abstract of  GB2478074  (A)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

A combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD). for use in the treatment of a tumour, to reduce cell viability, inhibit cell growth or reduce tumour volume. Preferably the tumour is a brain tumour, more specifically a glioma or glioblastoma. Preferably the compounds are in the ratio of 5:1 to 1:5. The cannabinoids may be present as plant extracts and may be administered separately, sequentially or simultaneously.

~~~

Inventor:

GUY GEOFFREY [GB] 
ROBSON PHILIP [GB]

Applicant:

GW PHARMA LTD [GB]
Abstract of  US2011230549  (A1)
 
 
Translate this text into Tooltip 
      >

 

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

 
 

The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined ratio by weight of approximately 1:1 of CBD to THC.

 

First page clipping of US2011230549 (A1)














~~~

 
 
Inventor:
PAROLARO DANIELA [GB] 
MASSI PAOLA [GB] (+21)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP]
 
Abstract not available for AR080454  (A1)
Abstract of corresponding document: GB2478595  (A)
 
Translate this text into Tooltip 
      >
Select language

     

epo_google_translate_review.gif

 

One or more phytocannabinoids, selected from the group consisting of tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), tetrahydrocannabivarinic acid, (THCVA), tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), cannabidol (CBD), cannabigerol (CBG) and cannabichromene (CBC), are provided for use in the treatment of prostate cancer. Where present the THCVA is present in an isolated pytocannabinoid, the THCA, CBDA, CBD, CBG or CBC are present in the form of a BDS, and the THCV or CBDV are present in either an isolated form or in the form of a BDS. Alternatively, one or more phytocannabinoids or acid phytocannabinoids may be provided for use in the down regulation of ERK signaling and effect one or more of anti-proliferation, anti-metastasis or anti-angiogenesis in a human patient. Alternatively, one or more phytocannabinoid acid, excluding CBDA or CBDVA, may be provided, for use in medicine. Alternatively, a cannabis plant extract for use in medicine may comprise at least 50% w/w phytocannabinoid component, the non-phytocannabinoid component comprising a monoterpene fraction and a sesquiterpene fraction. Alternatively, an isolated CBD and/or CBD BDS may be provided for use in the treatment of a pre-cancerous symptom of colon cancer. Alternatively, a combination of phytocannabinoids together with a chemotherapeutic agent may be provided for use in the treatment of a glioma.

~~~

 
 
 
Inventor:
VELASCO DIEZ GUILLERMO [ES] 
GUZMAN PASTOR MANUEL [ES] (+2)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP]
 
Abstract not available for CO6341551  (A2)
Abstract of corresponding document: GB2460672  (A)
 
Translate this text into Tooltip 
      >
Select language

     

epo_google_translate_review.gif

 

The invention relates to the use of one or more cannabinoids, particularly tetrahydrocannabinol (THC) and/or cannabidiol (CBD) in combination with a non-cannabinoid chemotherapeutic agent in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (G B M). The non-cannabinoid chemotherapeutic agent maybe a selective estrogen receptor modulator (SERM) or an alkylating agent.

~~~

 
 
Inventor:
VELASCO DIEZ GUILLERMO [ES] 
GUZMAN PASTOR MANUEL [ES] (+3)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP]
 
Abstract not available for CO6382172  (A2)
Abstract of corresponding document: WO2009147439  (A1)
 
Translate this text into Tooltip 
      >
Select language

     

epo_google_translate_review.gif

 

 
First page clipping of CO6382172 (A2)
 

The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM).

 






~~~


…for Epilepsy

 
 
Inventor:
WHALLEY BENJAMIN [GB] 
WILLIAMS CLAIRE [GB] (+2)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP] (+1)
 
Abstract of  GB2479153  (A)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

The invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy, in particular epilepsy characterised by generalised seizures. CBDV may be used in an isolated form or as a botanical drug substance. Preferably, CBDV is used with one or more therapeutically effective phytocannabinoids such as tetrahydrocannabivarin (THCV) and cannabidiol (CBD), and in combination with a standard anti-epileptic drug, Also claimed is a cannabis plant extract for use in the treatment of epilepsy, the extract containing at least 50 wt% of a phytocannabinoid fraction including CBDV as principal phytocannabinoid and CBD as secondary phytocannabinoid, and a non-phytocannabinoid fraction including monoterpenes and sesquitelpenes. Preferably the cannabis plant extract further comprises THCV. Some of the examples relate only to the use of THCV or CBD in models of epilepsy.

~~~

 
 
Inventor:
WHALLEY BEN [GB] 
STEPHENS GARY [GB] (+4)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP]
 
Abstract of  CA2766082  (A1)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

This invention relates to the use of one or more cannabinoids in the treatment of epilepsy and more particularly to the use of one or a combination of cannabinoids in the treatment of generalized or partial seizure. In one embodiment it relates to the use of the cannabinoid THCV, as a pure or isolated compound, or as a plant extract in which significant amounts of any THC naturally present has been selectively removed. In another embodiment the phytocannabinoid is CBD.

~~~

 
 
Inventor:
WHALLEY BENJAMIN 
WILLIAMS CLAIRE (+2)
 
Applicant:
GW PHARMA LTD 
OTSUKA PHARMA CO LTD
 
Abstract of  AU2011234225  (A1)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 






First page clipping of AU2011234225 (A1)







 

This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid CBDV in combination with standard anti-epileptic drugs (SAEDs). Preferably the SAED is one of ethosuximide, valproate or phenobarbital.

 




~~~


 
 
Inventor:
WHALLEY BENJAMIN [GB] 
WILLIAMS CLAIRE [GB] (+1)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP]
 
Abstract of  GB2487712  (A)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

Use of the phytocannabinoid cannabidiol (CBD), at a dose of greater than 300 mg/day, in combination with a standard anti-epileptic drug (SAED) which acts via sodium or calcium channels, for the treatment of epilepsy. Preferably, the SAED is a drug modifying low-threshold or transient neuronal calcium currents, such as ethosuximide, or a drug reducing high-frequency neuronal firing and sodium-dependent action potentials and enhancing GABA effects, such as valproate. Types of epilepsy more particularly targeted are generalised seizures or temporal lobe seizures. Combinations including further phytocannabinoids, such as tetrahydrocannabivarin (THCV) and/or cannabidivarol (CBDV), in addition to CBD, are also considered. The examples relate to CBD combined with valproate (studies using the pentylenetetrazol (PTZ) and pilocarpine models), ethosuximide (in the PTZ model) or phenobarbital (in pilocarpine model).

~~~

 
 
Inventor:
WHALLEY BENJAMIN [GB] 
WILLIAMS CLAIRE [GB] (+2)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP]
 
Abstract of  GB2487183  (A)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

The phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy, in particular epilepsy characterised by generalised seizures or temporal lobe seizures where the CBDV may be used in an isolated form or as a botanical drug substance. Preferably, CBDV is used with one or more therapeutically effective phytocannabinoids such as tetrahydrocannabivarin (THCV) and cannabidiol (CBD), and in combination with a standard anti-epileptic drug selected from ethosuximide, valproate or phenobarbital. A cannabis plant extract for use in the treatment of epilepsy, wherein the extract comprises at least 50 wt% of a phytocannabinoid fraction including CBDV as principal phytocannabinoid and CBD as secondary phytocannabinoid, and a non-phytocannabinoid fraction including monoterpenes and sesquiterpenes is also outlined.

~~~

 
 
Inventor:
WHALLEY BEN [GB] 
STEPHENS GARY [GB] (+2)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP]
 
Abstract not available for AR080730  (A1)
Abstract of corresponding document: WO2011121351  (A1)
 
Translate this text into Tooltip 
      >
Select language

     

epo_google_translate_review.gif

 

 
First page clipping of AR080730 (A1)

This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid CBDV in combination with standard anti-epileptic drugs (SAEDs). Preferably the SAED is one of ethosuximide, valproate or phenobarbital.

 

 

(3)




~~~

for neuroprotectant and neuropathic pain…
 
 
 
Inventor:
GUY GEOFFREY [GB] 
PLATT BETTINA [GB]
 
Applicant:
GW PHARMA LTD [GB]
 
Abstract of  EP2332533  (A1)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

The invention relates to the use of cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration. In particular, the invention relates to use of one or more cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration, wherein the one or more cannabinoid-containing plant extracts comprise: i) a cannabinoid-containing fraction; and ii) a non-cannabinoid-containing fraction.

~~~

 
 
 
Inventor:
MAIONE SABATINO [IT] 
ROSSI FRANCESCO [IT] (+3)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP]
 
Abstract of  GB2491118  (A)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

One or more of the cannabinoids: cannabichromene (CBC), cannabigerol (CBG), cannabidivarin (CBDV), or tetrahydrocannabivarin (THCV) for use in the treatment of neuropathic pain. Preferably, the cannabinoid is cannabigerol (CBG), cannabidivarin (CBDV), or tetrahydrocannabivarin (THCV). Preferably, the neuropathic pain is peripheral neuropathic pain, and may be allodynia. The one or more cannabinoids may be present in an effective human daily dose, preferably between 5 mg and 100 mg. The one or more cannabinoids may be packaged for use for an extended treatment period, preferably at least 7 days. The one or more cannabinoids may be combined with one or more other medicinal substances, such as analgesics, antidepressants, and anticonvulsants. The cannabinoids may be prepared from purified whole plant extracts of cannabis plants, and may be dissolved in Ringerâ s solution/DMSO for intraperitoneal administration to animal models.

~~~

 
 
Inventor:
GUY GEOFFREY [GB] 
PLATT BETTINA [GB]
 
Applicant:
GW PHARMA LTD [GB]
 
Abstract of  GB2434312  (A)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

The invention relates to the use of extracts of cannabis plants for treating neurological degeneration .such as alzheimer's, huntingdon's and parkinson's diseases, dementia, multiple sclerosis, Downs syndrome, prion disease, palsy, spinal cord injury or alcohol induced neurotoxicity. Preferably the extract contains a cannabinoid:non-cannabinoid fraction in a ratio of between 60:40 90:10. The cannabinoid fraction may contain tetrahydrocannabinol (THC), cannabidiol (CBD), tetrahydrocannabidivarin (THCV), cannabigerol (CBG), cannabichromeme (CBC) tetrahydrocannabinolic acid (THCA), cannabidivarin (CBDV) and cannadidiolic acid (CBDA).

~~~

…for use with anti-psychotic medicament

 
 
Inventor:
KIKUCHI TETSURO [JP] 
MAEDA KENJI [JP] (+3)
 
Applicant:
GW PHARMA LTD [GB] 
OTSUKA PHARMA CO LTD [JP]
 
Abstract of  TW200936127  (A)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

The present invention relates to the use of one or more cannabinoids in combination with one or more anti-psychotic medicaments for use in the prevention or treatment of psychosis and psychotic disorders. Preferably the one or more cannabinoids are taken from the group: cannabidiol (CBD); cannabidiolic acid (CBDA); tetrahydrocannbidivarin (THCV); tetrahydrocannbidivarinin acid (THCVA); cannabichromene (CBC); cannabichromenic acid (CBCA); cannabigerol (CBG) and cannabigerolic acid (CBGA). Preferably the anti-psychotic medication is an atypical anti-psychotic medication.

~~~

...Arthritis

 
 
Inventor:
GUY GEOFFREY [GB] 
ROBSON PHILIP
 
Applicant:
GW PHARMA LTD [GB]
 
Abstract of  MXPA06014057  (A)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

The invention relates to the use of a combination of cannabinoids for the treatment of pain, inflammation and/or disease modification in arthritis. Preferably the cannabinoids are selected from cannabidiol (CBD) or cannabidivarin (CBDV) and delta-9-tetrahydrocannabinol (THC) or tetrahydrocannabinovarin (THCV). More preferably the cannabinoids are in a predefined ratio by weight of less than or equal to 19:1 of CBD or CBDV to THC or THCV.

 

~~~


 

~~~

…for "new use"???,..New use for Cannabinoid????…nothing new here!!~Truth  ;-)'

 
   (4)
 
for,..  the treatment of obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimers disease, bone disorders, obesity associated with type II (non-insulin dependent) diabetes) or in the treatment of drug, alcohol or nicotine abuse or dependency. THCV may also be used as an appetite suppressant for cosmetic weight loss and other preventative disease and/or disorders…
 
 
 
Inventor:
GUY GEOFFREY [GB] 
PERTWEE ROGER [GB]
 
Applicant:
GW PHARMA LTD [GB]
 
Abstract not available for KR20120028400  (A)
Abstract of corresponding document: GB2434097  (A)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

The cannabinoid tetrahydrocannabidivarin (THCV) acts as a neutral antagonist of the CB1 cannabinoid receptor, and may be used for the treatment of obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimers disease, bone disorders, obesity associated with type II (non-insulin dependent) diabetes) or in the treatment of drug, alcohol or nicotine abuse or dependency. THCV may also be used as an appetite suppressant for cosmetic weight loss. THCV may be prepared as a crude extract from a cannabis plant, a purified product or a synthetic molecule. Other neutral antagonists of the CB1 receptor may also be used for the treatment of CB1 related conditions.

~~~

 
 
Inventor:
STINCHCOMB AUDRA LYNN [US] 
GOLINSKI MIROSLAW JERZY [US] (+2)
 
Applicant:
ALLTRANZ INC
 
Abstract of  US2012289484  (A1)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

Described herein are [Delta]9-THC prodrugs, methods of making [Delta]9-THC prodrugs, formulations comprising [Delta]9-THC prodrugs and methods of using [Delta]9-THC. One embodiment described herein relates to the transdermal administration of a [Delta]9-THC prodrug for treating and preventing diseases and/or disorders.

~~~

 

 
 
Inventor:
KELLY BROOKS J [US]
 
Applicant:
BROOKS KELLY RES LLC [US]
 
Abstract of  US2012295968  (A1)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

The present invention relates to a pharmaceutical composition comprising [Delta]9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), and at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resvertrol, and combinations thereof, wherein the composition exhibits an increased but negated psychoactivity with concurrent enhancement in therapeutic potency of THC and/or CBD. The present invention is further directed to methods of treating one or more disease(s) or disorder(s) modulated by the activation of the Cannabinoid CB1 and/or CB2 receptors, by administering a therapeutically effective amount of the composition of the present invention to a subject in need thereof.

~~~

 
 
Inventor:
WHITTLE BRIAN ANTHONY [GB]
 
Applicant:
GW PHARMA LTD [GB]
 
Abstract not available for SI1542657  (T1)
Abstract of corresponding document: WO2004016246  (A1)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments comprising one or more cannabinoids via mucosal surfaces, comprising: at least one lipophilic medicament which comprises one or more cannabinoids, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55 % wt/wt of the formulation, the formulation is absent of a self emulsifying agent and/or a fluorinated propellant, and the cannabinoid(s) is/are present in the formulation in an amount greater than 10 mg/ml.

~~~

 
COMPOSITIONS COMPRISING CANNABINOIDS FOR TREATMENT OF NAUSEA, VOMITING, EMESIS, MOTION SICKNESS OR LIKE CONDITIONS

 
 
Inventor:
WHITTLE BRIAN [GB] 
JAVID FARIDEH AFSHIN [GB]
 
Applicant:
GW PHARMA LTD [GB]
 
Abstract of  US2012059062  (A1)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 


Cannabinoids, in particular CBD and CBDA and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness. In particular extracts of cannabis plants are presented which are rich in these substances and suitable for pharmaceutical use.

~~~

 
 
Inventor:
WHITTLE BRIAN [GB] 
GUY GEOFFREY [GB] (+2)
 
Applicant:
GW PHARMA LTD [GB]
 
Abstract not available for AT555833  (T)
Abstract of corresponding document: WO02089945  (A2)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 


Processes for preparing extracts of natural products such as plant material, and for preparing purified extracts from crude extracts of natural products, by extraction with hot gas. Apparatus suitable for use in preparing extracts of natural products are also described.

~~~

 
 
Inventor:
DAVIES ANDREW [GB] 
STEUP CHRISTIAN [DE]
 
Applicant:
STI PHARMACEUTICALS LTD [GB] 
DAVIES ANDREW [GB] (+1)
 
Abstract of  WO2009043395  (A2)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

According to the invention a pharmaceutical composition suitable for pulmonary administration comprising at least one cannabinoid, at lease one local anaesthetic and a pharmaceutical acceptable carrier, diluent or excipient is provided. Furthermore, the addition of a local anaesthetic to a composition suitable for pulmonary administration allows and improves the delivery and bioavailability of an accurate dose and also of repeated doses of cannabinoids. The term "cannabinoid", for the purpose of this invention, includes all major and minor cannnabinoids found in natural cannabis and hemp material that can be isolated and reproduced by synthetic means. This includes delta-9-Tetrahydrocannabinol (THC), delta-8-Tetrahydrocannabinol, Cannabidiol (CBD), Cannabinol (CBN), tetrahydrocannabinovarin (THCV), cannabidivarin (CBDV), cannabigerol (CBG) and cannabichromene (CBC).; In addition the term cannabinoid includes synthetic cannabinoids and further combinations and acids of said natural and synthetic cannabinoids. For administration of the pharmaceutical composition preferably a metered dose dispenser, especially a metered dose inhaler is used, although other inhaler devices are also included in the scope of the invention. The invention also includes use of a local anaestetic in the manufacturing of a medicament for pulmonary administration, wherein the local anaestetic prevents and/or alleviates a reflex coughing due to irritations of the administered aerosol. Furthermore the inventions includes a method for pulmonary administering a pharmaceutical composition to a patient, wherein said composition comprises at least one local anaestetic, which prevents reflex coughing in response to irritations and wherein said composition is administered by an inhaler.

~~~

 
 
Inventor:
WHITTLE BRIAN [GB] 
GUY GEOFFREY [GB]
 
Applicant:
GW PHARMACEUTICALS LTD [GB]
 
Abstract of  GB2381194  (A)
 
Translate this text into Tooltip 
      >

 

    ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
epo_google_translate_review.gif

 

Pharmaceutical formulations for use in the administration of medicaments, in particular lipophilic medicaments, via mucosal surfaces. In particular the invention relates to formulations which, upon hydration, form an emulsion containing the lipophilic medicament which is capable of adhering to a mucosal surface and allowing controlled release of the medicament. Also outlined are:
a cannabis-based pharmaceutical formulation comprising the cannabinoids cannabidiol (CBD) and tetrahydrocannabinol (THC) or the cannabinoids tetrahydrocannabinovarin (THCV) and cannabidivarin (CBDV);
and the use of cannabidiol (CBD) to extend the shelf-life of a pharmaceutical product comprising at least one biologically active compound.

~~~

 

 
The Killin' Time Band - Doesn't Make Sense (Marijuana Prohibition)
 
Uploaded on May 3, 2011
A pro Medicinal Marijuana & Industrial Hemp video by Canada's "The Killin' Time Band" The Song "Doesn't Make Sense" is a plea to world governments to decriminalize & Legalize Medicinal Marijuana & Industrial Hemp. The Hemp plant has over 50,000 uses that could help save our planet, boost our economy & ease the pain of our sick.............. It Doesn't Make Sense.

This song appears on the CD "3 Day Weekend" by The Killin' Time Band
to download this track or CD from itunes please follow this link:
 
Thank you for supporting independent music